Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.88)
# 1,721
Out of 4,496 analysts
359
Total ratings
32.1%
Success rate
-9.52%
Average return
Main Sectors:
Top Industries:
41 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NUVB Nuvation Bio | Reiterates: Buy | $8 | $3.00 | +166.67% | 10 | Jul 17, 2024 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $21 | $10.22 | +105.48% | 14 | Jul 17, 2024 | |
| RLAY Relay Therapeutics | Maintains: Buy | $20 → $18 | $8.60 | +109.30% | 14 | Jul 17, 2024 | |
| CRBU Caribou Biosciences | Reiterates: Buy | $9 | $2.30 | +292.16% | 9 | Jul 17, 2024 | |
| RVMD Revolution Medicines | Maintains: Buy | $44 → $56 | $46.14 | +21.37% | 13 | Jul 16, 2024 | |
| IMMX Immix Biopharma | Reiterates: Buy | $7 | $2.08 | +236.54% | 2 | Jul 9, 2024 | |
| TNGX Tango Therapeutics | Reiterates: Buy | $13 | $9.27 | +40.24% | 8 | Jul 9, 2024 | |
| BNTX BioNTech SE | Reiterates: Buy | $113 | $85.46 | +32.23% | 29 | Jun 26, 2024 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $19 → $26 | $20.78 | +25.12% | 11 | Jun 18, 2024 | |
| COGT Cogent Biosciences | Reiterates: Buy | $19 | $8.61 | +120.67% | 6 | Jun 17, 2024 | |
| BDTX Black Diamond Therapeutics | Reiterates: Buy | $11 | $5.75 | +91.30% | 7 | Jun 7, 2024 | |
| REPL Replimune Group | Maintains: Buy | $12 → $17 | $9.89 | +71.89% | 9 | Jun 7, 2024 | |
| ELTX Elicio Therapeutics | Reiterates: Buy | $10 | $4.31 | +132.02% | 5 | Jun 6, 2024 | |
| ZYME Zymeworks | Reiterates: Neutral | $10 | $9.78 | +2.25% | 14 | Jun 6, 2024 | |
| AVBP ArriVent BioPharma | Reiterates: Buy | $25 | $18.77 | +33.19% | 3 | Jun 6, 2024 | |
| RPTX Repare Therapeutics | Reiterates: Buy | $10 | $3.90 | +156.41% | 13 | Jun 5, 2024 | |
| SWTX SpringWorks Therapeutics | Reiterates: Buy | $74 | $37.72 | +96.18% | 23 | Jun 4, 2024 | |
| PMVP PMV Pharmaceuticals | Reiterates: Buy | $5 | $1.56 | +220.51% | 9 | May 30, 2024 | |
| IGMS IGM Biosciences | Reiterates: Neutral | $12 | $10.74 | +11.73% | 12 | May 24, 2024 | |
| ATRA Atara Biotherapeutics | Reiterates: Neutral | n/a | $11.01 | - | 10 | May 22, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $10 → $9 | $2.83 | +218.02% | 10 | May 16, 2024 | |
| AADI Aadi Bioscience | Reiterates: Neutral | n/a | $1.43 | - | 10 | May 14, 2024 | |
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $21 → $22 | $11.59 | +89.82% | 10 | May 13, 2024 | |
| MGNX MacroGenics | Maintains: Neutral | $16 → $4 | $4.92 | -18.70% | 13 | May 13, 2024 | |
| OMGA Omega Therapeutics | Reiterates: Buy | $12 | $1.79 | +570.39% | 8 | May 13, 2024 | |
| APLM Apollomics | Maintains: Buy | $5 → $2 | $0.21 | +859.23% | 5 | May 8, 2024 | |
| ADCT ADC Therapeutics | Maintains: Buy | $9 → $8 | $3.44 | +132.56% | 15 | May 7, 2024 | |
| EXEL Exelixis | Reiterates: Buy | $28 | $22.60 | +23.89% | 2 | May 3, 2024 | |
| KRON Kronos Bio | Maintains: Buy | $2.5 → $2.25 | $1.25 | +80.00% | 8 | May 3, 2024 | |
| VIRX Viracta Therapeutics | Reiterates: Buy | $4 | $0.55 | +630.59% | 8 | Apr 16, 2024 | |
| EFTR eFFECTOR Therapeutics | Reiterates: Buy | $24 | $0.06 | +43,536.36% | 4 | Mar 28, 2024 | |
| CLDI Calidi Biotherapeutics | Maintains: Buy | $11 → $2 | $1.76 | +13.64% | 2 | Mar 21, 2024 | |
| PRLD Prelude Therapeutics | Downgrades: Neutral | $5 | $5.16 | -3.10% | 8 | Feb 20, 2024 | |
| KA Kineta | Reiterates: Buy | $8 | $0.69 | +1,066.01% | 4 | Jan 18, 2024 | |
| PRTG Portage Biotech | Downgrades: Neutral | n/a | $0.23 | - | 6 | Jan 8, 2024 | |
| GTBP GT Biopharma | Reiterates: Buy | $150 | $2.75 | +5,354.55% | 6 | Aug 8, 2023 | |
| IKNA Ikena Oncology | Reiterates: Buy | $22 | $1.66 | +1,225.30% | 4 | Mar 17, 2023 | |
| FATE Fate Therapeutics | Downgrades: Neutral | $115 → $7 | $4.27 | +63.93% | 6 | Jan 24, 2023 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $12 → $11 | $1.38 | +697.10% | 1 | Dec 22, 2021 | |
| NCNA NuCana | Maintains: Buy | $250 → $225 | $2.98 | +7,450.34% | 7 | Nov 24, 2021 | |
| MOLN Molecular Partners AG | Assumes: Buy | n/a | $6.23 | - | 1 | Jun 21, 2021 |
Nuvation Bio
Jul 17, 2024
Reiterates: Buy
Price Target: $8
Current: $3.00
Upside: +166.67%
ORIC Pharmaceuticals
Jul 17, 2024
Reiterates: Buy
Price Target: $21
Current: $10.22
Upside: +105.48%
Relay Therapeutics
Jul 17, 2024
Maintains: Buy
Price Target: $20 → $18
Current: $8.60
Upside: +109.30%
Caribou Biosciences
Jul 17, 2024
Reiterates: Buy
Price Target: $9
Current: $2.30
Upside: +292.16%
Revolution Medicines
Jul 16, 2024
Maintains: Buy
Price Target: $44 → $56
Current: $46.14
Upside: +21.37%
Immix Biopharma
Jul 9, 2024
Reiterates: Buy
Price Target: $7
Current: $2.08
Upside: +236.54%
Tango Therapeutics
Jul 9, 2024
Reiterates: Buy
Price Target: $13
Current: $9.27
Upside: +40.24%
BioNTech SE
Jun 26, 2024
Reiterates: Buy
Price Target: $113
Current: $85.46
Upside: +32.23%
Nurix Therapeutics
Jun 18, 2024
Maintains: Buy
Price Target: $19 → $26
Current: $20.78
Upside: +25.12%
Cogent Biosciences
Jun 17, 2024
Reiterates: Buy
Price Target: $19
Current: $8.61
Upside: +120.67%
Black Diamond Therapeutics
Jun 7, 2024
Reiterates: Buy
Price Target: $11
Current: $5.75
Upside: +91.30%
Replimune Group
Jun 7, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $9.89
Upside: +71.89%
Elicio Therapeutics
Jun 6, 2024
Reiterates: Buy
Price Target: $10
Current: $4.31
Upside: +132.02%
Zymeworks
Jun 6, 2024
Reiterates: Neutral
Price Target: $10
Current: $9.78
Upside: +2.25%
ArriVent BioPharma
Jun 6, 2024
Reiterates: Buy
Price Target: $25
Current: $18.77
Upside: +33.19%
Repare Therapeutics
Jun 5, 2024
Reiterates: Buy
Price Target: $10
Current: $3.90
Upside: +156.41%
SpringWorks Therapeutics
Jun 4, 2024
Reiterates: Buy
Price Target: $74
Current: $37.72
Upside: +96.18%
PMV Pharmaceuticals
May 30, 2024
Reiterates: Buy
Price Target: $5
Current: $1.56
Upside: +220.51%
IGM Biosciences
May 24, 2024
Reiterates: Neutral
Price Target: $12
Current: $10.74
Upside: +11.73%
Atara Biotherapeutics
May 22, 2024
Reiterates: Neutral
Price Target: n/a
Current: $11.01
Upside: -
Allogene Therapeutics
May 16, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $2.83
Upside: +218.02%
Aadi Bioscience
May 14, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.43
Upside: -
Y-mAbs Therapeutics
May 13, 2024
Maintains: Buy
Price Target: $21 → $22
Current: $11.59
Upside: +89.82%
MacroGenics
May 13, 2024
Maintains: Neutral
Price Target: $16 → $4
Current: $4.92
Upside: -18.70%
Omega Therapeutics
May 13, 2024
Reiterates: Buy
Price Target: $12
Current: $1.79
Upside: +570.39%
Apollomics
May 8, 2024
Maintains: Buy
Price Target: $5 → $2
Current: $0.21
Upside: +859.23%
ADC Therapeutics
May 7, 2024
Maintains: Buy
Price Target: $9 → $8
Current: $3.44
Upside: +132.56%
Exelixis
May 3, 2024
Reiterates: Buy
Price Target: $28
Current: $22.60
Upside: +23.89%
Kronos Bio
May 3, 2024
Maintains: Buy
Price Target: $2.5 → $2.25
Current: $1.25
Upside: +80.00%
Viracta Therapeutics
Apr 16, 2024
Reiterates: Buy
Price Target: $4
Current: $0.55
Upside: +630.59%
eFFECTOR Therapeutics
Mar 28, 2024
Reiterates: Buy
Price Target: $24
Current: $0.06
Upside: +43,536.36%
Calidi Biotherapeutics
Mar 21, 2024
Maintains: Buy
Price Target: $11 → $2
Current: $1.76
Upside: +13.64%
Prelude Therapeutics
Feb 20, 2024
Downgrades: Neutral
Price Target: $5
Current: $5.16
Upside: -3.10%
Kineta
Jan 18, 2024
Reiterates: Buy
Price Target: $8
Current: $0.69
Upside: +1,066.01%
Portage Biotech
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.23
Upside: -
GT Biopharma
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.75
Upside: +5,354.55%
Ikena Oncology
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.66
Upside: +1,225.30%
Fate Therapeutics
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $4.27
Upside: +63.93%
CytomX Therapeutics
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $1.38
Upside: +697.10%
NuCana
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $2.98
Upside: +7,450.34%
Molecular Partners AG
Jun 21, 2021
Assumes: Buy
Price Target: n/a
Current: $6.23
Upside: -